Personal Information

Dr. Shailendra Pratap Singh

Assistant Professor and Coordinator
Department of Medical Laboratory Technology
Assistant Professor
Department of Sports Bio-Sciences

Ph.D., CSIR-Indian Institute of Chemical Technology, Hyderabad. CSIR-NET LS, ICMR-SRF Post-Doc.- Kansas University Medical Center, USA; Post-Doc., Research Scientist- NYMC, New York, USA (2013-2020); Visiting Faculty- NYMC, New York, USA,

spsingh@curaj.ac.in

8287230934

Sudden Cardiac Arrest; Metabolic Syndrome: High Blood Pressure and abnormal Cholesterol levels; Diabetes & Insulin Resistance; Cardiovascular Diseases; Kidney damage and Fibrosis;

Our study aims to find a new target and the molecular processes that govern changes in metabolism, sudden cardiac arrest, metabolic rate, oxygen use, and insulin sensitivity in skeletal muscle, cardiac muscle, adipose tissue, and during normal activity as well as sports and exercise. PGC-1a is connected to turning on genes that help with fatty acid oxidation and mitochondrial biogenesis. It also raises the expression of GLUT4 in muscle cells. The mitochondrial respiratory chain is the means by which ATP is generated within mitochondria, the cellular powerhouses

 

Download The file ( bytes) jpg Icon

 

 

 

 

Education

  • Ph.D. Biotechnology, CSIR-Indian Institute of Chemical Technology, Hyderabad. 
  • Post-Doc., Kansas University Medical Center, Kansas, USA
  • Post-Doc., New York Medical College, New York, USA.
  • Research Scientist- New York University, New York, USA

Visiting Professor 

  • Visiting Faculty: New York Medical College, New York, USA
  • Visiting professor at the Center for Higher Studies in Human and Health Sciences at the Inter-American Open University in Buenos Aires, Argentina
  • Visiting professor at the Petrovsky National Research Center of Surgery, Russia, Moscow

Fellowship/ Awards

  • CSIR-UGC-National EligibilityT est (National Aptitude Screening Test conducted by CSIR-UGC), GOI, New Delhi, 2007.
  • Junior Research Fellow-Project, IICT Hyderabad (Department of Biotechnology, New Delhi), 2008
  • Senior Research Fellow-Project (Indian Council of Medical Research, New Delhi), 2011
  • 2018 Cell Signaling Technology, USA, Grant Program Grand Prize Winner of USD 5000
  • The most innovative faculty of the year 2020 was given by the DHS Foundation, New Delhi, in collaboration with Campbell University, North Carolina, USA.
  • Research Excellence Award 2020 by Institute of Scholars (InSc)
  • Awarded UGC-Funded-DSKothari Postdoctoral fellowship 2020
  • I was selected for the Scientist II position in the Department of Anatomy at the All India Institute of Medical Sciences in New Delhi, India but Prefer to join CURAJ
  • Awarded with Best Paper Presenter in the International Conference on Emerging Need to Strengthen Global Public Health Policy and Sports Sciences 2023, organized by SMIT, India, held on February 25–27.
  • Co-Chairman of the 3rd Technical Session at the 7TH NATIONAL CONFERENCE OF SPORTS SCIENCES PEFI, held in New Delhi.

WORK EXPERIENCE

  • January 2020 – May 2022 with the Central University of Rajasthan as an Assistant Professor in the Department of Biomedical Engineering
  • Awarded National Institutes of Health (NIH), USA Sponsored Research Scientist Position 2018 - 2020 with New York Medical College, New York, USA, Department of Pharmacology 
  • Awarded National Institutes of Health (NIH), USA Sponsored Postdoctoral Research Position 2015 - 2018 with New York Medical College, New York, the USA
  • Awarded National Institutes of Health (NIH), USA Sponsored Postdoctoral Research Position  2013 - 2015 with The Kidney Institute, Kansas University Medical Center, the USA

 

 

 

 

 

 

 

 

 

My lab is working on 

  • Sports Biochemistry
  • Sports Nutrition
  • Sports Physiology

Finding new targets for metabolic syndrome (MetS) includes obesity, high cholesterol, insulin resistance, and high blood pressure. Coronary heart disease and heart attacks are more likely in metabolic syndrome. In metabolic cardiomyopathy, there are structural and functional abnormalities, interstitial fibrosis, and no coronary artery disease or hypertension symptoms. Muscle has endocrine and paracrine activities. Myokines are muscle proteins that allow communication with the liver, adipose tissue, pancreas, bone, and cardiovascular system. Reduced physical activity and sarcopenia (muscle mass and strength loss) contribute to senior frailty and impairment. Coronary heart disease and heart attack are more common in metabolic syndrome. In metabolic cardiomyopathy, structural and functional alterations and interstitial fibrosis occur without coronary artery disease or excessive blood pressure. The muscle is an endocrine and paracrine organ. Skeletal muscle mass, the pancreas, bone, liver, adipose tissue, and cardiovascular system interact with myokine-derived secretory proteins. Scapopenia (loss of lean muscle mass and strength) and declining physical activity are associated with frailty and impairment in the elderly.

 

Editor of International Journals: 

  • Frontier in Pharmacology
  • Biomedicines
  • International Journal of Molecular Sciences
  • Journal of Obesity 
  • Biomedical Research and Practice
  • Journal of Cell Biology 
  • Journal of Cardiology
  • Reviewer of International Journals:
  • Frontier in Pharmacology
  • Biomedicines
  • International Journal of Molecular Sciences
  • Journal of Obesity 
  • Biomedical Research and Practice
  • Journal of Cell Biology 
  • Journal of Cardiology
  • PLOM
  • Cells
  • International Journal of Obesity
  • Cardiovascular diseases

 

 

 

 

 

 

 

 

 

S. No. Authors Title of Article Journal/Conference Details Journal/Conference Publication Year
1 1

  1. 1.     Cardiovascular & Hematological Agents in Medicinal Chemistry. The Role of Gut Microbiota and Associated Compounds in Cardiovascular Health and Its Therapeutic Implications.

  2. Lu Liu, Abhinav Kanwal, Avinash Kumar, Shailendra Pratap Singh. The International Journal of Gastroenterology and Hepatology Diseases.  Acetaldehyde and Butyrate: Their Biological Effects on the Liver and the Gut Axis.
  3. Abhinav Kanwal, Lu Liu, Puneet Kumar Bansal, Hemant Kumar, and Shailendra Pratap Singh, 2023. Applied In Vitro Toxicology, Vol. 9, No. 3. Apoptotic Cell Death in Cardiomyocytes Induced by Hypoxia from Cobalt Chloride Is Hastened by SGLT-1 Inhibition.
  4. K. P. Divya, Parneet Hari, Navjot Kanwar, Navita Aggarwal, Preeti Singh Dhoat, Lu Liu, Abhinav Kanwal,and Shailendra Pratap Singh. Advanced Gut & Microbiome Research/2023, , Article ID 5431615, 15 pages. The Role of the Gut Microbiome and the Hepatic Axis in the Pathogenesis of Metabolic Syndrome and Therapeutics
  5. Shweta Chauhan, Sanjib Patra, Shailendra Pratap Singh, Jitendra Lakhani Volume 14, Issue 3, May–June 2023, 100718. Journal of Ayurveda and Integrative Medicine. Combined effect of yoga and naturopathy in uncomplicated varicose vein disease – a prospective randomized controlled trial. IF=2.4
  6. Shen, Singh et al (2022), Antioxidants,11, 1147. Adipocyte-Specific Expression of PGC1α Promotes Adipocyte Browning and Alleviates Obesity-Induced Metabolic Dysfunction in an HO-1-Dependent Fashion. IF=7.648
  7. Waldman, Singh et al (2022), Cells, 2022, 11(19), 3060. Silencing the Adipocytokine NOV: A Novel Approach to Reversing Oxidative Stress-Induced Cardiometabolic Dysfunction. IF=7.66
  8. Kanwal, Kanwar, Srivastava, Singh et al, Biomedicines 2022, 10(2), 331. Exploring New Drug Targets for Type 2 Diabetes: Success, Challenges and Opportunities. IF=6.08
  9. 9.     Singh et al, Mini-Reviews in Medicinal Chemistry 2022. SARS-CoV-2 infections, impaired tissue and metabolic health: Pathophysiology and potential therapeutics. IF=4.00

10.  Singh et al, (2021) Int. J. Mol. Sci. 2021, 22(15), 8180. Mitochondrial Modulations, Autophagy Pathways Shifts in Viral Infections: Consequences of COVID-19. IF=6.00

11.  Raj, Dsouza, Singh* and Kanwal* et al., (2020), Frontier in Pharmacology, 2020; 11: 598326. Sirt6 Deacetylase: A potential key regulator in the prevention of obesity, diabetes, and neurodegenerative disease. IF=5.641

12.  Raffaelle, Licari, Amin, Alex, Shen, Levy, Singh, et al (2020), IJMS, 21(15): 5469. Cold Press Pomegranate Seed Oil Attenuates Dietary-Obesity Induced Hepatic Steatosis and Fibrosis through Antioxidant and Mitochondrial Pathways in Obese Mice. IF=6.00

13.  Singh et al (2020), Antioxidants, 9(1) 40. Adipocyte Specific HMOX1 Gene Therapy is Effective in Antioxidant Treatment of Insulin Resistance and Vascular Function in an Obese Mice Model. IF=7.648

14.  Fakhouri, Weingarten, Singh et al (2021), Oxidative Medicine and Cellular Longevity, 2021-11-24. The Association of Nephroblastoma Overexpressed (NOV) and Endothelial Progenitor Cells with Oxidative Stress in Obstructive Sleep Apnea. IF= 6.543

15.  Singh et al (2019), Obesity, 27(10):1634-1643. Cardioprotective Heme Oxygenase-1-PGC1α signaling in epicardial fat attenuates cardiovascular risk in humans as in obese mice. IF=5.002

16.  Raffaele, Bellner, Singh et al (2019), Experimental Cell Research, 380(2):180-187. Epoxyeicosatrienoic Intervention Improves NAFLD in Leptin Receptor Deficient Mice by an Increase in PGC1-HO-1-mitochondrial Signaling. If=4.00

17.  Peterson, Shapiro, Thompson, Singh, et al (2019), Obesity, 27(1):87-93. Oxidized HDL, Adipokines and Endothelial Dysfunction: A Potential Biomarker Profile for Cardiovascular Risk in Women with Obesity. IF=5.002

18.  Shailendra P. Singh, Olivier Huck, Nader G. Abraham, Salomon (2018), J Immunol 201 (5): 1491–1499. Kavain Reduces Porphyromonas gingivalis–Induced Adipocyte Inflammation: Role of PGC-1α.IF= 5.43

19.  Gilani A, Pandey V, Garcia V, Agostinucci K, Singh et al (2018), AJP Regul Integr Comp Physiol; 1;315(5): R934-R944. High-fat diet-induced obesity and insulin resistance in CYP4A14-/- mice is mediated by 20-HETE.IF=3.61

20.  Liu, Puri, Raffaele, Schragenheim, Singh, et al (2018) Prostaglandins Other Lipid Mediat, 138:1-8. Ablation of Soluble Epoxide Hydrolase Expression Increases Beige Fat Over White Fat Through an Increase in Mitochondrial Integrity, Insulin Sensitivity, and HO-1-PGC1α-adiponectin in-vitro and invivo. IF=3.017

21.  Singh et al, (2018) Cardiovascular Pharmacology 233 (6:233). CYP-450 Epoxygenase Derived Epoxyeicosatrienoic Acid Contribute to Reversal of Heart Failure in Obesity- Induced Diabetic Cardiomyopathy via PGC-1α Activation. IF=2.79

22.  Sacerdoti*, Singh*et al (2018) Int. J of Hepatology:14. Development of NASH in Obese Mice is Confounded by Adipose Increase in Inflammatory NOV and Oxidative Stress.IF=2.84

23.  Schragenheim, Bellner, Cao, Singh, et al, (2018), Prostaglandins Other Lipid Mediat. 137: 30-39. Cytochrome-epoxygenase-derived EET Improves Sodium Excretion and Perirenal Adipose tissues Function in Obese Mice via activation of the PGC-1. IF=3.017

24.  Weingarten, Bellner, Peterson, Zaw, Chadha, Singh, et al (2017), 31(2).  Horm Mol Biol Clin Investig. The association of NOV/CCN3 with obstructive sleep apnea (OSA): preliminary evidence of a novel biomarker in OSA. IF=2.19

25.  Singh et al (2017), Horm Mol Biol Clin Investig, 31(1). Ablation of Adipose-HO-1 Expression Increases White Fat Over Beige Fat Through Inhibition of Mitochondrial Fusion and PGC1α in Female Mice. IF=2.19

26.  Cao, Singh et al (2017), AJP Heart and Circulatory Physiology, 313(2): H368-H380. EET Intervention on Wnt1, NOV, and HO-1 Signaling Prevents Obesity-Induced Cardiomyopathy in Obese Mice. IF=3.864

27.  Singh et al (2016), Journal of nutrition and metabolism. Downregulation of PGC-1α Prevents the Beneficial Effect of EET-Heme Oxygenase-1 on Mitochondrial Integrity and Associated Metabolic Function in Obese Mice.IF= 2.89

28.  Singh et al (2016), Prostaglandins Other Lipid Mediat. 125:8-18.  PGC-1 alpha Regulates HO-1 Expression and Mitochondrial Dynamics and Biogenesis: Role of Epoxyeicosatrienoic Acid. IF=3.017

29.  Waldman, Bellner, Vanella, Schragenheim, Sodhi, Singh, et al, (2016) Stem Cells Dev, 25(14):1084-94. Epoxyeicosatrienoic Acids Regulate Adipocyte Differentiation of Mouse 3T3 Cells, Via PGC-1α Activation, which is Required for HO-1 Expression and Increased Mitochondrial Function. IF=3.471

30.  Peterson, Vanella, Gotlinger, Jiang, Singh, et al, (2016) Prostaglandins Another Lipid Mediat 123:68-77. Oxidized HDL is a potent inducer of adipogenesis and causes activation of the Ang-II and 20-HETE systems in human obese females. IF=3.017

31.  Singh et al, (2015), Disease Models & Mechanisms 8, 931- 940. Glycogen Synthase Kinase-3 Inhibition Attenuates Fibroblast Activation and Development of Fibrosis Following Renal Ischemia/Reperfusion In Mice. IF=6.00

32.  Singh et al (2016), Environ Sci Pollut Res Int 23(4):3914-24. Genotoxic effects of Chromium Oxide Nano and Microparticles in Wistar rats after 28 days of repeated oral exposure. IF=4.34

33.  Kumari, Singh, et al, (2014), Int J Toxicol. 33(2):86-97. Toxicity study of cerium oxide nanoparticles in human neuroblastoma cells.IF=2.03

34.  Singh et al (2013), J Appl Toxicol, 33(10):1165-79. Toxicity assessment of manganese oxide micro and nanoparticles in Wistar rats after 28 days of repeated oral exposure. IF=3.48

35.  Singh et al (2013) Mutat Res. 754(1-2):39-50. Genotoxicity of nano- and micron-sized manganese oxide in rats after acute oral treatment. IF=3.68

36.  Singh et al (2013), Toxicol Appl Pharmacol, 266(1):56-66. Comparative study of genotoxicity and tissue distribution of nano and micron-sized iron oxide in rats after acute oral treatment. IF=4.29

37.  Chinthala, Kumar, Sarfaraz, Singh et al (2013), Eur J Med Chem, 70:308-14. Synthesis, biological evaluation, and molecular modeling studies of some novel thiazolidinediones with triazole ring. IF=6.9  

38.  Kumari, Rajak, Singh, et al, (2013) Drug Chem Toxicol 36(3):296-305. Biochemical alterations induced by acute oral doses of iron oxide nanoparticles in Wistar rats. IF=2.09 

39.  Kumari, Rajak, Singh, et al (2012), J Nanosci Nanotechnol, 12(3):2149-59. Repeated oral dose toxicity of iron oxide nanoparticles: biochemical and histopathological alterations in different tissues of rats. IF=1.39 

40.  Kanwal, Singh et al (2012), Anal Biochem 429(1):70-5. Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2. IF=3.69 

41.  Mahboob, Rahman, Rekhadevi, Sailaja, Balasubramanyam, Prabhakar, Singh et al (2012), IJ Toxicol 19(1):20-4. Monitoring of oxidative stress in nurses occupationally exposed to antineoplastic drugs. IF=2.032 

42.  Prabhakar, Reddy, Singh, et al (2012) J Appl Toxicol, 32(6):436-45. Oxidative stress-induced by aluminum oxide nanomaterials after acute oral treatment in Wistar rats. IF=3.48

43.  Grover, Singh et al (2009), Food Chem Toxicol, 47(8):1964-71. In vivo assessment of genotoxic effects of Annona squamosa seed extract in rats. IF= 6.023

44.  Kanwal* and Singh* et al (2020) Biomed J Sci & Tech Res 30(3). Clinical Application of the Main Viral Proteinase (Mpro or 3clpro) Inhibitors for Coronavirus Therapy.

Book PUBLICATIONS

Book Chapter: Biological systems and Nano-Pharmacokinetics: Book Name- Nano-Pharmacokinetics and Theranostics: Advancing Cancer Therapy (2021) Publisher: Elsevier publications (ISBN 9780323859820)

Book Name: Nanotechnology applications and biomedical effects for future perspectives: Toxic effects of metal oxide nanoparticles (2020) by Dr. Shailendra Pratap Singh. Publisher-Exceller Publications (ISBN 978-93-90746-00-2)

ABSTRACT/CONFERENCES/ WORKSHOPS

  • 2009 Poster entitled “Genotoxicological effects of Iron oxide (Fe3O4) nanomaterial in Rats”was presented at Indo-US workshop on Nanotechnology- Applications and Implications” Nov. 10 - 12, 2009 at IICT, Hyderabad, India.

  • 2012 Delivered a talk on “Genotoxicity assessment of Chromium oxide nanoparticles in albino Wistar rats” was presented at “International Conference “Global Meet of Biologists”Dec. 26 - 28 Dec 2012 at IICT, Hyderabad, India.

  • 2014 Dr. Jared J. Grantham Symposium Future Directions of PKD Research The Kidney Institute at the University of Kansas Medical Center May 7- 9, 2014 Kansas City, MO, USA

  • 2015 K-INBRE Symposium delivered a talk on “Role of GSK3b in Acute Kidney injury” was presented at Kansas University Medical Center, USA

  • 2015 Poster entitled “Glycogen Synthase Kinase-3 Regulates Fibroblast Activation and Development of Fibrosis following Renal Ischemia/Reperfusion in Mice” was presented at Kansas University Medical Center, USA

  • EET-agonist Prevents and Reverses Heart Failure in Obesity Induced Diabetic Cardiomyopathy. SP Singh, JA McClung, L Bellner, J Schragenheim, NG Abraham. The FASEB Journal 32 (1_supplement), 561.7-561.7

  • EET Enhances Renal Function in Obese Mice Resulting in Restoration of Mfn1/2 Signaling and a Decrease in Hypertension Through Inhibition of Sodium Chloride Co-Transporter. J Schragenheim, L Bellner, SP Singh, JA McClung, D Bamshad, ...The FASEB Journal 32 (1_supplement), 561.13-561.13

  • EET-mediated Recruitment of PGC-1 alpha, Restores Mitochondrial Function, LV Function, and Ameliorates Development of Cardiovascular Disease in Db Mice That is Reversed by L Bellner, J Cao, G Joseph, J Schragenheim, SP Singh, A Kappas, ... Hypertension 68.

  • Activation of Pgc1 alpha by EET Stimulates Insulin Sensitivity, Normalizes Blood Pressure and Increases Mitochondrial Oxphos in Obese Mice. SP Singh, M Waldman, J Schragenheim, L Bellner, J Cao, M Arad, ... Hypertension 68.

  • Diabetic Cardiomyopathy is Reversed by Increased Mitochondrial Bioenergetics Due to PGC-1 alpha Activation by EET Treatment of Obese Mice. J Cao, JA McClung, SP Singh, L Bellner, M Waldman, J Schragenheim, ... Hypertension 68

  • Abstract P233: Diabetic Cardiomyopathy is Reversed by Increased Mitochondrial Bioenergetics Due to PGC-1α Activation by EET Treatment of Obese Mice. J Cao, JA McClung, SP Singh, L Bellner, M Waldman, J Schragenheim, ...Hypertension 68 (suppl_1), AP233-AP233.

  • Abstract P172: Activation of Pgc1α by EET Stimulates Insulin Sensitivity, Normalizes Blood Pressure and Increases Mitochondrial Oxphos in Obese Mice. SP Singh, M Waldman, J Schragenheim, L Bellner, J Cao, M Arad, ... Hypertension 68 (suppl_1), AP172-AP172.

  • Abstract P127: EET-mediated Recruitment of PGC-1α, Restores Mitochondrial Function, LV Function, and Ameliorates Development of Cardiovascular Disease in Db Mice That is L Bellner, J Cao, G Joseph, J Schragenheim, SP Singh, A Kappas, ... Hypertension 68 (suppl_1), AP127-AP127.

  • Hmox1 Activation Reprograms White Fat to Beige Adipose Tissue Through Recruitment of Cyp2C44-derived EET, pAMPK-PGC1α That Enhances Mitochondrial Mfn2 and Opa1. NG Abraham, SP Singh, L Bellner, D Bamshad, G Drummond. Hypertension 68 (suppl_1), A079- A079.

  • PGC-1α is a Critical Activator of HO-1 That Protects Against Cardiomyopathy in Diabetic Mice Through Recruitment of Mitochondrial Fusion Proteins and Function. J Cao, JA McClung, M Waldman, SP Singh, J Schragenheim, M Arad, ... Hypertension 68 (suppl_1), A024-A024.

  • UPACRI-JULY,2020 a Virtual Conference on multidisciplinary research and innovations organized by DHS foundation, New Delhi in collaborations with Campwell University, North Carolina, USA.

 

 

 

 

 

 

 

 

 

  • Co-PI for BIRAC e-YUVA centre by BIRAC- Incubation and Entrepreneurship Development for RS. 20000000/- Government of India 2024
  • PI-Received Rs.10,00000/- INR of Seed Grant 2022 by CuRaj.
  • PI-Project titled "The impact of various factors on the permeability of the endothelial barrier in the pathogenesis of cardiovascular diseases; the development of corrective therapies.". By DST-SERB for Rs. 31,50000/- INR 2023
  • Co-PI-Titled “Establishment of inclusive TBI at Central University of Rajasthan” submitted for setting up Inclusive Technology Business Incubator (i-TBI). By DST for Rs. 5,29,09000/-INR

PATENT: Details of Patent “Edible Oil Quality Monitoring Device” (The patent office journal No.52/2022 dated 30/12/2022; P.81600) date of publication 30-12-2022

Sr No.

CUPB/
CUHP/ EXTERNAL

Title

Inventor

Filing Date

Application No

Publication date

Journal No.

 

713

PB

EDIBLE OIL QUALITY MONITORING SYSTEM

PRATEEK SRIVASTAVA, JASMINDER K SANDHU, DEEPAM GOYAL, S K MITTAL, SHAILENDRA PARTAP SINGH, ASHIWANI KUMAR

02-12-2022

202211069733

30-12-2022

52/2022

The Patent Office Journal No. 52/2022 Dated 30/12/2022 P. 81600

 

 

 

 

 

 

 

 

Attended

MEMBERSHIPS

  • American Society for Pharmacology and Experimental Therapeutics
  • American Association for the Advancement of Science (AAAS- 60044979)
  • The New York Academy of Sciences (NYAS)

CONFERENCE/MEETINGS:

  • American society of nephrology meeting, San Diego (USA), 2015
  • American Heart Association meeting, Orlando Florida (USA) 2016
  • 17th International Winter Eicosanoid Conference, Baltimore, MD (USA) 2018  
  • American Diabetes Association (ADA -548271899

  • The Purina institute microbiome forum virtual events 2021, October 20-21 2021. Putting microbiome science in to clinical Practice. St Louis Missouri, USA.

  • National Bioengineering conference 2022, 6-7th Jan 2022, NIT Rourkela, India

  • Awarded with Best paper presenter in the International Conference on Emerging Need to Strengthen Global Public Health Policy and Sports Sciences -2023 organized SMIT, India, held on 25-27th February.
  • Co-Chairman at 3rd Technical session at 7TH NATIONAL CONFERENCE OF SPORTS SCIENCES PEFI, New Delhi

BEYOND WORK: - EDITORIALS & PANEL JUDGING: NOTABLE ACCOMPLISHMENTS ACROSS THE CAREER

  • Academic editor in different Journals (A) A) Frontiers in Pharmacology, section Experimental Pharmacology and Drug Discovery; (B) Biomedicines (C) Vaccines (D) Vaccines(https://www.mdpi.com/journal/vaccines).
  • Served as a Poster Judge many times at the Summer Training in Academic Research (STAR) research forum, GSRF- Graduate senior research forum at New York Medical College, New York, USA. Invited to Judge a poster session at Westchester Science and Engineering Fair -An INTEL-ISEF affiliated fair AT Sleepy Hollow High School 210 North Broadway, Sleepy Hollow, and NY 10591 ON Saturday, March 17, 2018
  • Serving as a reviewer for more than 20 research Journals with high impact factors and reviewed more than 100 research articles from very high impact factor journals i.e. International Journal of nanomedicine,  Clinical Interventions in Aging, Journal of Experimental Pharmacology, Diabetes, Metabolic Syndrome, and Obesity: Targets and Therapy, Frontier in pharmacology, Stem cell international, Cellular physiology and biochemistry, Cardiovascular Therapeutics, Canadian Journal of Physiology and Pharmacology, Colloids and Surfaces B and PLOS ONE
  • Analytical biochemistry paper was highlighted by nature India News 2012  which comprised of Technique to screen anti-diabetic drugs. Indian Institute of Chemical Technology, Hyderabad: Development of a cell-based nonradioactive glucose uptake assay system for SGLT1 and SGLT2
  • The research was used as a reference for a method by Detroit R&D, MI, USA to measure Mito copy no (Mitochondrial Copy Number PCR-Based Kits Real-Time PCR DNA Mitochondrial Quantification for Human, Mouse, and Rat).

FDPs/Orientations/Refresher course

  • Attended 21 days of FDP/Orientation/TLC course in January 2021
  • Attended 15 days Refresher course in research methodology from Jan. 23, 2023 - Feb. 6, 2023
  • Attended 7days FDP course on National Education Policy-2020 from 20-26 March, 2023

Invited Talk

  • Invited talk given at MDS University, Ajmer on "Metabolic syndrome with special reference to diabetes and Cardiovascular diseases," December 23, 2022.
  • Awarded with Best paper presenter in the International Conference on Emerging Need to Strengthen Global Public Health Policy and Sports Sciences -2023 organized SMIT, India, held on 25-27th February.

 

Organized